Bill M.

Bill M. has extensive experience in the oncology field, currently serving as an Executive Oncology Therapeutic Specialist at Incyte Corp since September 2011, where the focus is on meeting unmet medical needs through research and innovation. Prior to this role, Bill M. spent 14 years at Novartis as a Sr Oncology Sales Specialist, contributing to the launch of several key oncology products such as Sandostatin LAR, Zometa, Gleevec, and Afinitor, while also being a part of the Cornerstone Club. Bill M. holds an MBA in Finance and Management from Mount St. Mary's University and a BS in Marketing and Accounting from Pennsylvania State University.